Literature DB >> 19273668

Plasmodium falciparum Na+/H+ exchanger 1 transporter is involved in reduced susceptibility to quinine.

Maud Henry1, Sébastien Briolant, Agnès Zettor, Stéphane Pelleau, Meili Baragatti, Eric Baret, Joel Mosnier, Rémy Amalvict, Thierry Fusai, Christophe Rogier, Bruno Pradines.   

Abstract

Polymorphisms in the Plasmodium falciparum crt (Pfcrt), Pfmdr1, and Pfmrp genes were not significantly associated with quinine (QN) 50% inhibitory concentrations (IC(50)s) in 23 strains of Plasmodium falciparum. An increased number of DNNND repeats in Pfnhe-1 microsatellite ms4760 was associated with an increased IC(50) of QN (P = 0.0007). Strains with only one DNNND repeat were more susceptible to QN (mean IC(50) of 154 nM). Strains with two DNNND repeats had intermediate susceptibility to QN (mean IC(50) of 548 nM). Strains with three DNNND repeats had reduced susceptibility to QN (mean IC(50) of 764 nM). Increased numbers of NHNDNHNNDDD repeats were associated with a decreased IC(50) of QN (P = 0.0020). Strains with profile 7 for Pfnhe-1 ms4760 (ms4760-7) were significantly associated with reduced QN susceptibility (mean IC(50) of 764 nM). The determination of DNNND and NHNDNHNNDDD repeats in Pfnhe-1 ms4760 could be a good marker of QN resistance and provide an attractive surveillance method to monitor temporal trends in P. falciparum susceptibility to QN. The validity of the markers should be further supported by analyzing more isolates.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19273668      PMCID: PMC2681529          DOI: 10.1128/AAC.01243-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  34 in total

1.  Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum.

Authors:  M B Reed; K J Saliba; S R Caruana; K Kirk; A F Cowman
Journal:  Nature       Date:  2000-02-24       Impact factor: 49.962

2.  Profile and evolution of the chemosusceptibility of falciparum malaria imported into France in 2000.

Authors:  P Ralaimazava; R Durand; N Godineau; A Keundjian; Z Jezic; B Pradines; O Bouchaud; J Le Bras
Journal:  Euro Surveill       Date:  2002-07

3.  The epidemiology of drug-resistant malaria.

Authors:  A Björkman; P A Phillips-Howard
Journal:  Trans R Soc Trop Med Hyg       Date:  1990 Mar-Apr       Impact factor: 2.184

4.  Evidence of artemisinin-resistant malaria in western Cambodia.

Authors:  Harald Noedl; Youry Se; Kurt Schaecher; Bryan L Smith; Duong Socheat; Mark M Fukuda
Journal:  N Engl J Med       Date:  2008-12-08       Impact factor: 91.245

Review 5.  Clindamycin in malaria treatment.

Authors:  P G Kremsner
Journal:  J Antimicrob Chemother       Date:  1990-01       Impact factor: 5.790

6.  Response of Kampuchean strains of Plasmodium falciparum to antimalarials: in-vivo assessment of quinine and quinine plus tetracycline; multiple drug resistance in vitro.

Authors:  M Giboda; M B Denis
Journal:  J Trop Med Hyg       Date:  1988-08

7.  Variations in the sequence and expression of the Plasmodium falciparum chloroquine resistance transporter (Pfcrt) and their relationship to chloroquine resistance in vitro.

Authors:  Valérie Durrand; Antoine Berry; Rithy Sem; Philippe Glaziou; Joelle Beaudou; Thierry Fandeur
Journal:  Mol Biochem Parasitol       Date:  2004-08       Impact factor: 1.759

8.  Dissecting the loci of low-level quinine resistance in malaria parasites.

Authors:  Michael T Ferdig; Roland A Cooper; Jianbing Mu; Bingbing Deng; Deirdre A Joy; Xin-zhuan Su; Thomas E Wellems
Journal:  Mol Microbiol       Date:  2004-05       Impact factor: 3.501

9.  Multiple transporters associated with malaria parasite responses to chloroquine and quinine.

Authors:  Jianbing Mu; Michael T Ferdig; Xiaorong Feng; Deirdre A Joy; Junhui Duan; Tetsuya Furuya; G Subramanian; L Aravind; Roland A Cooper; John C Wootton; Momiao Xiong; Xin-zhuan Su
Journal:  Mol Microbiol       Date:  2003-08       Impact factor: 3.501

10.  Synchronization of Plasmodium falciparum erythrocytic stages in culture.

Authors:  C Lambros; J P Vanderberg
Journal:  J Parasitol       Date:  1979-06       Impact factor: 1.276

View more
  36 in total

1.  Differential association of Plasmodium falciparum Na+/H+ exchanger polymorphism and quinine responses in field- and culture-adapted isolates of Plasmodium falciparum.

Authors:  Stéphane Pelleau; Lionel Bertaux; Sébastien Briolant; Michael T Ferdig; Véronique Sinou; Bruno Pradines; Daniel Parzy; Ronan Jambou
Journal:  Antimicrob Agents Chemother       Date:  2011-09-26       Impact factor: 5.191

2.  Limited ability of Plasmodium falciparum pfcrt, pfmdr1, and pfnhe1 polymorphisms to predict quinine in vitro sensitivity or clinical effectiveness in Uganda.

Authors:  Frederick N Baliraine; Samuel L Nsobya; Jane Achan; James K Tibenderana; Ambrose O Talisuna; Bryan Greenhouse; Philip J Rosenthal
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

3.  In vitro sensitivity of Plasmodium falciparum clinical isolates from the China-Myanmar border area to quinine and association with polymorphism in the Na+/H+ exchanger.

Authors:  Hao Meng; Rongping Zhang; Henglin Yang; Qi Fan; Xinzhuan Su; Jun Miao; Liwang Cui; Zhaoqing Yang
Journal:  Antimicrob Agents Chemother       Date:  2010-07-19       Impact factor: 5.191

Review 4.  Know your enemy: understanding the role of PfCRT in drug resistance could lead to new antimalarial tactics.

Authors:  Robert L Summers; Megan N Nash; Rowena E Martin
Journal:  Cell Mol Life Sci       Date:  2012-06       Impact factor: 9.261

5.  Atorvastatin as a potential antimalarial drug: in vitro synergy in combinational therapy with dihydroartemisinin.

Authors:  Hélène Savini; Jean Baptiste Souraud; Sébastien Briolant; Eric Baret; Rémy Amalvict; Christophe Rogier; Bruno Pradines
Journal:  Antimicrob Agents Chemother       Date:  2009-11-30       Impact factor: 5.191

6.  Polymorphisms in Pfmdr1, Pfcrt, and Pfnhe1 genes are associated with reduced in vitro activities of quinine in Plasmodium falciparum isolates from western Kenya.

Authors:  Jelagat Cheruiyot; Luicer A Ingasia; Angela A Omondi; Dennis W Juma; Benjamin H Opot; Joseph M Ndegwa; Joan Mativo; Agnes C Cheruiyot; Redemptah Yeda; Charles Okudo; Peninah Muiruri; Ngalah S Bidii; Lorna J Chebon; Paul O Angienda; Fredrick L Eyase; Jacob D Johnson; Wallace D Bulimo; Ben Andagalu; Hoseah M Akala; Edwin Kamau
Journal:  Antimicrob Agents Chemother       Date:  2014-04-21       Impact factor: 5.191

7.  Plasmodium falciparum Na+/H+ exchanger (pfnhe-1) genetic polymorphism in Indian Ocean malaria-endemic areas.

Authors:  Valérie Andriantsoanirina; Nimol Khim; Arsene Ratsimbasoa; Benoit Witkowski; Christophe Benedet; Lydie Canier; Christiane Bouchier; Magali Tichit; Rémy Durand; Didier Ménard
Journal:  Am J Trop Med Hyg       Date:  2012-12-03       Impact factor: 2.345

8.  Association of microsatellite variations of Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene with reduced in vitro susceptibility to quinine: lack of confirmation in clinical isolates from Africa.

Authors:  Valérie Andriantsoanirina; Didier Ménard; Stéphane Rabearimanana; Véronique Hubert; Christiane Bouchier; Magali Tichit; Jacques Le Bras; Rémy Durand
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

Review 9.  Global analysis of Plasmodium falciparum Na(+)/H(+) exchanger (pfnhe-1) allele polymorphism and its usefulness as a marker of in vitro resistance to quinine.

Authors:  Didier Ménard; Valérie Andriantsoanirina; Nimol Khim; Arsène Ratsimbasoa; Benoit Witkowski; Christophe Benedet; Lydie Canier; Odile Mercereau-Puijalon; Rémy Durand
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-10-26       Impact factor: 4.077

10.  Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum.

Authors:  Véronique Parquet; Maud Henry; Nathalie Wurtz; Jerome Dormoi; Sébastien Briolant; Marine Gil; Eric Baret; Rémy Amalvict; Christophe Rogier; Bruno Pradines
Journal:  Malar J       Date:  2010-05-25       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.